US firm Codexis and Shasun Chemicals and Drugs of India have signed
a manufacturing and supply agreement for a pharmaceutical
intermediate for a generic drug.
Italy's fine chemicals industry organisation, Afaquim, is
organising a conference in September aimed at coordinating the
efforts of European active pharmaceutical ingredient (API)
suppliers in the face of increasing competition...
Solutia has elected to retain its Pharmaceutical Services Division
(PSD) despite suggestions that a spin out or sale of the business
were being considered, reports Phil Taylor.
Teva Hungary, a subsidiary of number two generic company Teva
Pharmaceuticals, is to build a $100 million (€75m) factory for the
production of active pharmaceutical ingredients (APIs) in
Sajobabony, Hungary.
Hungary's Richter Gedeon reported rises in both overall sales and
profits in 2004, although its active pharmaceutical ingredient
(API) business remained under pressure in the US.
Akzo Nobel has reported a sharp rise in profits for 2004, but
warned that 2005 would be tough and that further divestments in its
chemicals portfolio are planned.
Flarer, a Swiss company specialising in methods of drug delivery,
has developed a new chewing gum production technology that extends
the range of active pharmaceutical ingredients (API) that can be
delivered via this route.
German chemicals group BASF has launched two new pharmaceutical
film-coating products, cementing its position in a market estimated
to be worth about €200 million and growing at 5 to 6 per cent a
year.
Manufacturers of active pharmaceutical ingredients (APIs) can
reduce the risk of exposure to highly toxic active ingredients
using a new process system developed by Collette, part of Niro
Pharma Systems.
With just a few weeks to go before the introduction of India's new
patent regime - which will increase protection to include product
as well as process patents - a group of government Ministers is
calling for a waiver that would...
Cambrex has recorded a loss in the third quarter of this year after
writing down goodwill in its biopharma division in a move that
paints a pessimistic picture of the market for outsourced
manufacturing of biological drugs.
Danish company Niro has forged closer links with US firm
International Specialty Products to develop technologies aimed at
enhancing the bioavailability of active pharmaceutical ingredients
(APIs).
Finland's Kemira has completed the divestment of its fine chemicals
business, which now operates as KemFine under the control of the
division's former management team.
Germany's Girindus is this year's recipient of the Product
Differentiation Award sponsored by consulting firm Frost &
Sullivan for its innovative developments in the commercial
production of oligonucleotides.
Major pharmaceutical and generics players are continuing to invest
in plants for the production of active pharmaceutical ingredients,
with Pfizer, Ivax, Berlex and Protein Design Labs all announcing
new ventures in the last few days.
Aspen Pharmacare, Africa's largest pharmaceutical manufacturer, has
been told that it can retain a recently purchased manufacturing
facility for off-patent active pharmaceutical ingredients (APIs),
providing it continues to supply...
The market for pharmaceutical fine chemicals will remain static
until 2005 and overcapacity will continue to be a problem, predicts
Global Pharmaceutical Fine Chemicals - Industry and Market
Analysis, a new report from Urch Publishing.
India's Jubilant Organosys has bought two companies in Belgium as
part of a drive to improve its presence in the European market for
generic drugs and active pharmaceutical ingredients (APIs).
The well established Pharmaceutical Substances database of active
pharmaceutical ingredients (APIs), published by Germany's Thieme,
is now available for the first time in an online format.
Israeli press reports say US generics company IVAX is close to
finalising a merger with local firm Agis, which manufactures
generics and active pharmaceutical ingredients (APIs).
DSM will cut around 500 jobs at its Chemelot site in Geleen, the
Netherlands over the next two years, in an effort to cut costs by
over €50 million per annum. The jobs will largely go in support
services and manufacturing staff departments.
It is no secret that India is becoming a major force in the world
market for active pharmaceutical ingredients, but recent
developments suggest that companies in the country may be gearing
up to play a similar role in inactive ingredients.
German contract ingredient manufacturer Girindus posted its first
profit since it was floated on the stock exchange in 2000 in the
last quarter of 2003, as sales rose 16 per cent to €32 million.
US chemicals firm Aceto has bought the German Pharma Waldhof
business from Switzerland's Roche, making its first foray into the
market for biologically-derived active pharmaceutical ingredients
(APIs).
The restructuring activity that has features this year in the
European pharmachem industry continued yesterday with the news that
Germany's Merck KGaA had sold off BioMer, a joint venture focusing
on orthopaedic products.
Japan's Sumitomo Chemical is absorbing its wholly-owned Sumika Fine
Chemicals subsidiary and combining it with its own activities in
this area to bolster its role as a supplier of pharmaceutical
chemicals.
Cambrex has appointed a new CEO to oversee the combination of its
small-molecule and biological active pharmaceutical ingredient
(API) activities into a single business unit.
Eisai has announced a further hike in investment in manufacturing
in order to cope with increasing overseas demand for its
top-selling Aciphex and Aricept products.
EaglePicher Pharmaceutical Services (EPPS) of the USA says it has
received $1.8 million (€1.5m) in late-stage development contracts
for active pharmaceutical ingredients (API).
Germany's BASF has been awarded a US patent covering a new coating
agent, binder and/or film-forming excipient, based on
polyether-containing polymers, which can be used in pharmaceutical
formulations
Aldo Magnini has been appointed managing director of Clariant's
pharmaceuticals ingredients manufacturing business in Italy, based
around the company's two manufacturing plants in Origgio and Isso.
BASF AG's Fine Chemicals division is expanding production of
pharmaceutical active ingredients with the construction of a new
plant at its site in Minden, Germany. A spokesman for the company
told In-pharmatechnologist.com that...